Non-small Cell Lung Cancer Map and Analysis: Exploring Interconnected Oncogenic Signal Integrators

Overview

Journal Mamm Genome

Specialty Genetics

Date 2025 Feb 12

PMID 39939487

Authors

Sai Bhavani Gottumukkala

Anbumathi Palanisamy

Affiliations

Soon will be listed here.

Abstract

Non-Small Cell lung cancer (NSCLC) is known for its fast progression, metastatic potency, and a leading cause of mortality globally. At diagnosis, approximately 30-40% of NSCLC patients already present with metastasis. Epithelial to mesenchymal transition (EMT) is a developmental program implicated in cancer progression and metastasis. Transforming Growth Factor-β (TGFβ) and its signalling plays a prominent role in orchestrating the process of EMT and cancer metastasis. In present study, a comprehensive molecular interaction map of TGFβ induced EMT in NSCLC was developed through an extensive literature survey. The map encompasses 394 species interconnected through 554 reactions, representing the relationship and complex interplay between TGFβ induced SMAD dependent and independent signalling pathways (PI3K/Akt, Wnt, EGFR, JAK/STAT, p38 MAPK, NOTCH, Hypoxia). The map, built using Cell Designer and compliant with SBGN and SBML standards, was subsequently translated into a logical modelling framework using CaSQ and dynamically analysed with Cell Collective. These analyses illustrated the complex regulatory dynamics, capturing the known experimental outcomes of TGFβ induced EMT in NSCLC including the co-existence of hybrid EM phenotype during transition. Hybrid EM phenotype is known to contribute for the phenotypic plasticity during metastasis. Network-based analysis identified the crucial network level properties and hub regulators, while the transcriptome-based analysis cross validated the prognostic significance and clinical relevance of key regulators. Overall, the map developed and the subsequent analyses offer deeper understanding of the complex regulatory network governing the process of EMT in NSCLC.

References

Adorno M, Cordenonsi M, Montagner M, Dupont S, Wong C, Hann B . A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell. 2009; 137(1):87-98. DOI: 10.1016/j.cell.2009.01.039. View

Aghamiri S, Singh V, Naldi A, Helikar T, Soliman S, Niarakis A . Automated inference of Boolean models from molecular interaction maps using CaSQ. Bioinformatics. 2020; 36(16):4473-4482. PMC: 7575051. DOI: 10.1093/bioinformatics/btaa484. View

Al Bakir M, Huebner A, Martinez-Ruiz C, Grigoriadis K, Watkins T, Pich O . The evolution of non-small cell lung cancer metastases in TRACERx. Nature. 2023; 616(7957):534-542. PMC: 10115651. DOI: 10.1038/s41586-023-05729-x. View

Araki S, Eitel J, Batuello C, Bijangi-Vishehsaraei K, Xie X, Danielpour D . TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer. J Clin Invest. 2009; 120(1):290-302. PMC: 2798681. DOI: 10.1172/JCI39194. View

Asgarova A, Asgarov K, Godet Y, Peixoto P, Nadaradjane A, Boyer-Guittaut M . PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma. Oncoimmunology. 2018; 7(5):e1423170. PMC: 5927541. DOI: 10.1080/2162402X.2017.1423170. View

Attisano L, Wrana J . Signal transduction by members of the transforming growth factor-beta superfamily. Cytokine Growth Factor Rev. 1996; 7(4):327-39. DOI: 10.1016/s1359-6101(96)00042-1. View

Baarsma H, Engelbertink L, van Hees L, Menzen M, Meurs H, Timens W . Glycogen synthase kinase-3 (GSK-3) regulates TGF-β₁-induced differentiation of pulmonary fibroblasts. Br J Pharmacol. 2013; 169(3):590-603. PMC: 3682707. DOI: 10.1111/bph.12098. View

Bai L, Yu Z, Zhang J, Yuan S, Liao C, Jeyabal P . OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3β/snail/E-cadherin signaling. Oncotarget. 2016; 7(9):10402-13. PMC: 4891128. DOI: 10.18632/oncotarget.7224. View

Bandyopadhyay A, Agyin J, Wang L, Tang Y, Lei X, Story B . Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor. Cancer Res. 2006; 66(13):6714-21. DOI: 10.1158/0008-5472.CAN-05-3565. View

10.

Bedi A, Chang X, Noonan K, Pham V, Bedi R, Fertig E . Inhibition of TGF-β enhances the in vivo antitumor efficacy of EGF receptor-targeted therapy. Mol Cancer Ther. 2012; 11(11):2429-39. PMC: 3640459. DOI: 10.1158/1535-7163.MCT-12-0101-T. View

11.

Blobe G, Schiemann W, Lodish H . Role of transforming growth factor beta in human disease. N Engl J Med. 2000; 342(18):1350-8. DOI: 10.1056/NEJM200005043421807. View

12.

Borthwick L, Gardner A, Soyza A, Mann D, Fisher A . Transforming Growth Factor-β1 (TGF-β1) Driven Epithelial to Mesenchymal Transition (EMT) is Accentuated by Tumour Necrosis Factor α (TNFα) via Crosstalk Between the SMAD and NF-κB Pathways. Cancer Microenviron. 2011; 5(1):45-57. PMC: 3343199. DOI: 10.1007/s12307-011-0080-9. View

13.

Brabletz T, Lyden D, Steeg P, Werb Z . Roadblocks to translational advances on metastasis research. Nat Med. 2013; 19(9):1104-9. PMC: 3972758. DOI: 10.1038/nm.3327. View

14.

Camerlingo R, Miceli R, Marra L, Rea G, DAgnano I, Nardella M . Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation. PLoS One. 2019; 14(7):e0219597. PMC: 6657837. DOI: 10.1371/journal.pone.0219597. View

15.

Cao M, Seike M, Soeno C, Mizutani H, Kitamura K, Minegishi Y . MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells. Int J Oncol. 2012; 41(3):869-75. PMC: 3582905. DOI: 10.3892/ijo.2012.1535. View

16.

Cao L, Qi L, Zhang L, Song W, Yu Y, Xu C . Human nonsense-mediated RNA decay regulates EMT by targeting the TGF-ß signaling pathway in lung adenocarcinoma. Cancer Lett. 2017; 403:246-259. DOI: 10.1016/j.canlet.2017.06.021. View

17.

Caraci F, Gili E, Calafiore M, Failla M, La Rosa C, Crimi N . TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol Res. 2008; 57(4):274-82. DOI: 10.1016/j.phrs.2008.02.001. View

18.

Casas E, Kim J, Bendesky A, Ohno-Machado L, Wolfe C, Yang J . Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res. 2011; 71(1):245-54. PMC: 3025803. DOI: 10.1158/0008-5472.CAN-10-2330. View

19.

Castanon E, Soltermann A, Lopez I, Roman M, Ecay M, Collantes M . The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche. Cancer Lett. 2017; 402:43-51. DOI: 10.1016/j.canlet.2017.05.012. View

20.

Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti G, Papotti M . Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res. 2010; 8(9):1207-16. DOI: 10.1158/1541-7786.MCR-10-0052. View